Company Profile LogoCardiff Oncology

Cardiff Oncology is develops drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers.

Edit IconSuggest an Edit
Oncology
Medical
Health Diagnostics
Health Care
Biotechnology

    Unlock insights on Cardiff Oncology and 2M+ companies now!

    About Cardiff Oncology

    Cardiff Oncology is a clinical-stage oncology therapeutics company developing drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers. It has a broad intellectual property and proprietary technology to measure circulating tumor DNA (ctDNA) in urine and blood to identify and quantify clinically actionable markers for predicting response to cancer therapies. The company offers its PCM technology at its CLIA/CAP-accredited laboratory and plans to continue

    Company Highlights
    Year Founded

    1999

    icon-altEmployees

    58

    Location (HQ)

    USA

    Since Last Funding

    2 years 9 months

    Monthly Website Visitors

    4.7K

    icon-altTotal Investment Amt

    $80M

    icon-altYoY Headcount Growth

    11.52%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Health Care

    Medical

    Biotechnology

    Biotechnology Research

    Health Diagnostics

    Oncology